Tumori: aumentano gli studi di fase I in Italia, oltre 100 nel 2023“Più benefici per i pazienti. In 20 anni raddoppiati i tassi di risposta”

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Enter your email Address

Immediapress

Tumori: aumentano gli studi di fase I in Italia, oltre 100 nel 2023“Più benefici per i pazienti. In 20 anni raddoppiati i tassi di risposta”